U of I study reports global decrease in explicit bias
CHAMPAIGN-URBANA, Ill. (WCIA) — A study by University of Illinois researchers found that self-reported bias, or explicit bias, has decreased globally. Implicit — or automatic — bias has seen a bit more variation over the years.
The researchers tracked explicit and implicit bias against stigmatized groups in 33 countries between 2009 to 2019. The categories they looked at included race, body weight, skin tone and sexuality.
U of I Extension hosting annual agriculture contest for high school students
University of Illinois Urbana-Champaign psychology professor Benedek Kurdi led the research along with Tessa Charlesworth, a professor in the Kellogg School of Management at Northwestern University.
'We used data from Project Implicit, a website established in the early 2000s that serves both as a venue to educate people about implicit processes and as a site for collecting data,' Kurdi said.
People are aware of their explicit biases towards groups or individuals. Implicit biases, however, may be hidden. To understand a person's implicit biases, researchers may have a person take on a task, while performing a behavior.
Solidarity Gardens CU giving out free garden plots
For example, a research participant may be tasked with categorizing images and words and analyzing how quickly they accomplish this can allow researchers to make inferences about their implicit biases. Kurdi said this is because there is less of a chance for the research participant to control their responses.
After analyzing data from participants in the U.S., previous studies found that self-reported bias against stigmatized groups has been going down. U.S. research participants have expressed less anti-old/pro-young, anti-fat/pro-thin, anti-gay/pro-straight, anti-dark skin/pro-light skin and anti-Black/pro-white attitudes since 2007.
Implicit bias for some stigmatized groups has also been trending down in the U.S.
Community Spotlight: Champaign County Forest Preserve District summer camps
'Specifically, implicit sexuality attitudes dropped in bias by 65% and are now close to neutrality. Implicit race and skin tone attitudes have also [showed declines in bias], although at slower but still notable rates of 26% and 25%, respectively,' the researchers said.
For body weight and age, however, implicit bias remained high in the U.S.
When comparing U.S. trends to global data, the researchers found results that were similar, but with a couple of key differences.
'We looked at self-reported bias against age, body weight, sexuality, skin tone and race,' Kurdi said. 'And for every single one of them, people are reporting less bias, and they are reporting more egalitarian social group attitudes. But then when you look at implicit attitudes, there is a lot more variability.'
WATCH: UIPD seeking tips after 3 people damage Foellinger Auditorium
Between 2009 to 2019, self-reported bias fell internationally, between 18% to 43% for each of the stigmatized groups that the researchers focused on.
Implicit bias varied a bit more, however. Implicit bias related to sexuality dropped 36%, and age, race and body weight stayed pretty much the same. Implicit bias related to skin tone decreased, but then later increased by about 20% overall between 2009 to 2019.
Kurdi said that a key finding is that explicit and implicit bias are malleable. And he noted that the most dramatic reductions in bias — in the U.S. and abroad — were related to sexuality.
'It's not just that the average is changing, but almost every single country in the dataset changed toward less bias in sexuality attitudes,' Kurdi said. 'This is likely the result of several factors, including social movements, people coming out, and the fact that representation of gay people has become both more frequent and more diverse in media.'
For more details on the study, you can find the research paper online.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
5 hours ago
- Newsweek
Black Woman Left Stunned by Genetics of Both Children: 'Came Out Blonde'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A mom from Colorado was left stunned by her two children who have defied genetics. Nadiyah Luwan Smith (@nadiismiith) posted a clip on TikTok of her two children—both born with blue eyes and blonde hair, despite having predominantly Black and Puerto Rican heritage. In the video, Smith captures her son, Kuhvari X'Xivion Simmons-Smith, who is three-quarters Black and one-quarter white, and her daughter, Malaïa Louwella Smith, who is half Black and half Puerto Rican. Nadiyah Luwan Smith's 6-month-old baby who is one-quarter white and three-quarters black with blonde hair and blue eyes. Nadiyah Luwan Smith's 6-month-old baby who is one-quarter white and three-quarters black with blonde hair and blue eyes. @nadiismiith Both children, however, have inherited features commonly associated with European ancestry: fair skin, blonde hair and blue eyes. Smith's mind was blown by genetics in her multiracial babies. "My son's father is half Black and half white, I'm full Black, so my son is a quarter white and three quarters Black," the 26-year-old told Newsweek. "My daughter's father is Puerto Rican, so she's half Puerto Rican and Black." She and her husband Charles Robert Simmons, 28, were expecting more brown features, since Black is the most dominant race in both cases. Both Smith's parents are Black, with brown hair and brown eyes—traits she inherited as well. Simmons, though adopted, knows his biological father is also Black with brown hair and brown eyes. His mother, however, is white with blonde hair and blue eyes—a genetic detail that turned out to play a key role in their children's appearance. When their son, was born with blonde hair and blue eyes, "we were honestly stunned," Smith said. "The whole pregnancy we were just picturing a more brown baby considering Black is our most dominant race between us," she continued. "So when he came out blonde hair, blue eyes we had to ask ourselves who he inherited his features from. Sure enough it was grandma!" Smith's clip went viral within a few days of posting. Pinned to her profile, the 20-second clip has been viewed over 312,000 times. Dozens of users commented, many of whom shared their own stories of how genetics have played out in their children. "Mine are opposite! One-quarter Black, three-quarters white. They're all 4 different, but you can tell they're all siblings," one user wrote. "My daughter is half Black, one-quarter Mexican, one-quarter white. She has natural blonde 4a hair," another shared. "My kids are one-quarter Black and three-quarters white and they both didn't get my blue eyes. But my daughter did get light brown straight hair and their dad and I both have dark curly hair. You just never know!"
Yahoo
20 hours ago
- Yahoo
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) in multiple preclinical models of chronic cough compared to reference drugs. Some of these preclinical data with Addex GABAB PAM drug candidate will be presented on June 7, 2025 at the 10th American Cough Conference, in Dulles, Virginia by Dr Mikhail Kalinichev, Head of Translational Science at Addex. In models of chronic cough, the GABAB PAM drug candidate significantly reduced citric acid-induced cough frequency, increased cough latency and showed no signs of tolerance after sub-chronic treatment. In the same model, the antitussive efficacy of the Addex GABAB PAM drug candidate appears to be superior to that observed with nalbuphine, baclofen, codeine or a P2X3 inhibitor. In addition, the tolerability of the GABAB PAM candidate demonstrated better tolerability and a wider therapeutic margin than that observed with nalbuphine, baclofen, or codeine, while being similar to that of a P2X3 inhibitor, based on the compound's activity on respiratory rate. 'The preclinical data obtained to date demonstrate the huge therapeutic potential of our highly selective GABAB PAM. Following in vivo proof of concept seen in a range of cough models, we are now ready to advance this candidate molecule into IND enabling studies,' said Dr Kalinichev. 'Chronic cough continues to be difficult to treat, and several different approaches being evaluated in clinical trials. Based on the data we have collected to date, we believe our GABAB PAM candidate has the potential to be an effective, once-daily treatment for patients with refractory chronic cough and other conditions.' 'This data with our novel, once daily, orally available GABAB PAM drug candidate clearly demonstrates the potential of our allosteric modulator approach to deliver a better effect than baclofen for this clinically validated drug target,' said Tim Dyer, CEO of Addex. 'Congratulations to the team and we look forward to advancing this candidate rapidly through IND enabling studies and into the clinic so we can hopefully provide better treatment options for patients.' About GABAB activation and cough: The main inhibitory neurotransmitter GABA activates ionotropic (GABAA) and metabotropic (GABAB) types of receptors. GABAB receptors are widely expressed on airways and in the central and peripheral components of the cough neural circuit. Activating GABAB receptors to treat chronic cough has been clinically validated with baclofen, a selective GABAB agonist, that binds the receptor within the GABA binding, orthosteric site. Baclofen is used off-label to treat chronic cough patients, but its wider use is limited due to serious side effects, short half-life and gradual loss of efficacy during chronic treatment. Targeting an allosteric site of the receptor encompasses many advantages, including higher selectivity, better tolerability and lack of tolerance compared to an orthosteric compound. About Addex Therapeutics:Addex is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is under evaluation for future development in brain injury recovery, including post-stroke and traumatic brain injury recovery. Addex's partner, Indivior, has selected a GABAB PAM drug candidate for development in substance use disorders and has successfully completed IND enabling studies. Addex is advancing an independent GABAB PAM program for chronic cough. Addex also holds a 20% equity interest in a private spin out company, Neurosterix LLC, which is advancing a portfolio of allosteric modulator programs, including M4 PAM for schizophrenia, mGlu7 NAM for mood disorders and mGlu2 NAM for mild neurocognitive disorders. Addex shares are listed on the SIX Swiss Exchange and American Depositary Shares representing its shares are listed on the NASDAQ Capital Market, and trade under the ticker symbol 'ADXN' on each exchange. For more information, visit Contacts: Tim DyerChief Executive OfficerTelephone: +41 22 884 15 55 PR@ Mike SinclairPartner, Halsin Partners+44 (0)7968 022075msinclair@ Addex Forward Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements about the intended use of proceeds of the offering. The words 'may,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'plan,' 'anticipate,' 'intend,' 'believe,' 'estimate,' 'predict,' 'project,' 'potential,' 'continue,' 'target' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release, are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, uncertainties related to market conditions. These and other risks and uncertainties are described in greater detail in the section entitled 'Risk Factors' in Addex Therapeutics' Annual Report on Form 20-F, prospectus and other filings that Addex Therapeutics may make with the SEC in the future. Any forward-looking statements contained in this press release represent Addex Therapeutics' views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Addex Therapeutics explicitly disclaims any obligation to update any forward-looking in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Writer shares troubling story about invisible threat impacting neighborhood where she grew up: 'We lived in the shadow'
Growing up, writer Reniqua Allen-Lamphere worried about gun violence. But as an adult, she's realized that the biggest danger to her childhood was invisible — but no less dangerous. Allen-Lamphere shared her story in The Guardian. Growing up in a peaceful community in Englewood, New Jersey, she spent most afternoons playing in a local park, where she would splash in the brook and enjoy the sunshine. But just beyond, the threat lurked. "We lived in the shadow of factories bordering our beloved park," she explained. "Companies such as the LeDoux Corporation, a chemical testing company that had worked on everything from the Manhattan Project to the moon landing, were just steps from the swings." And as more people began to suffer from seemingly unrelated, mysterious health issues — from endometriosis to diabetes — people began to wonder if those factories had something to do with them. One family friend of Allen-Lamphere's shared: "As kids, we always played in the brook and thought it was fun when the water changed colors and stained our hands. … Our neighborhood smelled like rotten eggs every day when we came home from school, which I now know was the smell of sulfur. I can only imagine the toxins we were exposed to." Nowadays, scientists have a better idea of the links between environmental pollution and health. Air pollution is now known to be linked with a plethora of issues, from respiratory illness to dementia, certain cancers, and cardiovascular issues, per the National Institute of Environmental Health. But Allen-Lamphere had personally suffered from severe menstrual pain and endometriosis, and a recent study from Human Rights Watch found that this, too, may have been exacerbated by the pollution. Researchers found links between air pollution and gestational diabetes, pre-eclampsia, and fibroids. And other common toxins and contaminants, including heavy metals and industrial chemicals, have been linked with infertility and endocrine disruption, leading to pregnancy complications. And unfortunately, people of color are disproportionately affected by this. Black people are 75% more likely to live within close range of industrial facilities, meaning that the air they breathe is, on average, 38% more polluted than the air in majority-white communities, per the Climate Reality Project. Researchers are looking into ways to reduce air pollution while simultaneously contributing to a greener future. From a team looking to convert methane into airplane fuel to another team reverse-engineering real dairy butter out of air-based carbon molecules, the potential solutions are vast and varied. But at its root, reducing air pollution means reducing it at the source and decreasing the amount of toxins and emissions generated in the first place. Both governmental regulations — such as the EPA's recent closing of loopholes on highly polluting steel plants — and initiatives by corporations, like transitioning shipping fleets to clean fuels, will be necessary for this. And as a citizen and a consumer, you can use your voting power and your money to contribute your own power to this effort. Do you worry about air pollution in and around your home? Yes — always Yes — often Yes — sometimes No — never Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.